Metrics
- Price
- $74.59
- Market Cap $M
- 6,579
- Rel Volume
- 0.68
- Vol Up 2W
- 55.60%
- Vol Trend 2W
- -0.60%
- 1D
- -1.67%
- 1W
- -5.59%
- 1M
- +3.00%
- 1M Slope
- +2.56%
- 6M Range
- 50.19%
- Score
- 75.2
- Sharp
- 3.8
Volume
Profile
CG Oncology develops immunotherapy treatments for bladder cancer, focusing on bladder-sparing therapies and other oncology programs for patients with urologic cancers.
Biotech
Pharmaceuticals